Human insulin Market Size, Share Report, Analysis, Trends, Growth 2032

Human insulin Market

Human insulin Market by Product (Drugs and Drug Delivery Devices), By Application (Insulin dependent diabetes mellitus (Type 1) and Non-Insulin dependent diabetes mellitus (Type 2)), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2024-2032

Category: Healthcare Report Format : PDF Pages: 180 Report Code: ZMR-101 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 21.88 Billion USD 48.51 Billion 8.3% 2023

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Product
        • 2.1.1.2. Market Attractiveness Analysis, By Application
        • 2.1.1.3. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Human insulin Market, 2016 – 2028 (USD Billion)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Human insulin Market – Product Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Product, 2020 & 2028
    • 4.2. Drugs
      • 4.2.1. Market Size and Forecast, By Region (USD Billion)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Drug Delivery Devices
      • 4.3.1. Market Size and Forecast, By Region (USD Billion)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Human insulin Market – Application Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Application, 2020 & 2028
    • 5.2. Insulin dependent diabetes mellitus (Type 1)
      • 5.2.1. Market Size and Forecast, By Region (USD Billion)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Non-Insulin dependent diabetes mellitus (Type 2)
      • 5.3.1. Market Size and Forecast, By Region (USD Billion)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.1. Overview
      • 6.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 6.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
    • 6.2. North America
      • 6.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.2.2. North America Market Revenue, By Product, 2016 – 2028
      • 6.2.3. North America Market Revenue, By Application, 2016 – 2028
      • 6.2.5. U.S.
        • 6.2.5.1. U.S. Market Revenue, By Product, 2016 – 2028
        • 6.2.5.2. U.S. Market Revenue, By Application, 2016 – 2028
      • 6.2.6. Canada
        • 6.2.6.1. Canada Market Revenue, By Product, 2016 – 2028
        • 6.2.6.2. Canada Market Revenue, By Application, 2016 – 2028
      • 6.2.7. Mexico
        • 6.2.7.1. Mexico Market Revenue, By Product, 2016 – 2028
        • 6.2.7.2. Mexico Market Revenue, By Application, 2016 – 2028
    • 6.3. Europe
      • 6.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.3.2. Europe Market Revenue, By Product, 2016 – 2028
      • 6.3.3. Europe Market Revenue, By Application, 2016 – 2028
      • 6.3.5. Germany
        • 6.3.5.1. Germany Market Revenue, By Product, 2016 – 2028
        • 6.3.5.2. Germany Market Revenue, By Application, 2016 – 2028
      • 6.3.6. France
        • 6.3.6.1. France Market Revenue, By Product, 2016 – 2028
        • 6.3.6.2. France Market Revenue, By Application, 2016 – 2028
      • 6.3.7. U.K.
        • 6.3.7.1. U.K. Market Revenue, By Product, 2016 – 2028
        • 6.3.7.2. U.K. Market Revenue, By Application, 2016 – 2028
      • 6.3.8. Italy
        • 6.3.8.1. Italy Market Revenue, By Product, 2016 – 2028
        • 6.3.8.2. Italy Market Revenue, By Application, 2016 – 2028
      • 6.3.9. Spain
        • 6.3.9.1. Spain Market Revenue, By Product, 2016 – 2028
        • 6.3.9.2. Spain Market Revenue, By Application, 2016 – 2028
      • 6.3.10. Rest of Europe
        • 6.3.10.1. Rest of Europe Market Revenue, By Product, 2016 – 2028
        • 6.3.10.2. Rest of Europe Market Revenue, By Application, 2016 – 2028
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.4.2. Asia Pacific Market Revenue, By Product, 2016 – 2028
      • 6.4.3. Asia Pacific Market Revenue, By Application, 2016 – 2028
      • 6.4.5. China
        • 6.4.5.1. China Market Revenue, By Product, 2016 – 2028
        • 6.4.5.2. China Market Revenue, By Application, 2016 – 2028
      • 6.4.6. Japan
        • 6.4.6.1. Japan Market Revenue, By Product, 2016 – 2028
        • 6.4.6.2. Japan Market Revenue, By Application, 2016 – 2028
      • 6.4.7. India
        • 6.4.7.1. India Market Revenue, By Product, 2016 – 2028
        • 6.4.7.2. India Market Revenue, By Application, 2016 – 2028
      • 6.4.8. South Korea
        • 6.4.8.1. South Korea Market Revenue, By Product, 2016 – 2028
        • 6.4.8.2. South Korea Market Revenue, By Application, 2016 – 2028
      • 6.4.9. South-East Asia
        • 6.4.9.1. South-East Asia Market Revenue, By Product, 2016 – 2028
        • 6.4.9.2. South-East Asia Market Revenue, By Application, 2016 – 2028
      • 6.4.10. Rest of Asia Pacific
        • 6.4.10.1. Rest of Asia Pacific Market Revenue, By Product, 2016 – 2028
        • 6.4.10.2. Rest of Asia Pacific Market Revenue, By Application, 2016 – 2028
    • 6.5. Latin America
      • 6.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.5.2. Latin America Market Revenue, By Product, 2016 – 2028
      • 6.5.3. Latin America Market Revenue, By Application, 2016 – 2028
      • 6.5.5. Brazil
        • 6.5.5.1. Brazil Market Revenue, By Product, 2016 – 2028
        • 6.5.5.2. Brazil Market Revenue, By Application, 2016 – 2028
      • 6.5.6. Argentina
        • 6.5.6.1. Argentina Market Revenue, By Product, 2016 – 2028
        • 6.5.6.2. Argentina Market Revenue, By Application, 2016 – 2028
      • 6.5.7. Rest of Latin America
        • 6.5.7.1. Rest of Latin America Market Revenue, By Product, 2016 – 2028
        • 6.5.7.2. Rest of Latin America Market Revenue, By Application, 2016 – 2028
    • 6.6. The Middle-East and Africa
      • 6.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.6.2. The Middle-East and Africa Market Revenue, By Product, 2016 – 2028
      • 6.6.3. The Middle-East and Africa Market Revenue, By Application, 2016 – 2028
      • 6.6.5. GCC Countries
        • 6.6.5.1. GCC Countries Market Revenue, By Product, 2016 – 2028
        • 6.6.5.2. GCC Countries Market Revenue, By Application, 2016 – 2028
      • 6.6.6. South Africa
        • 6.6.6.1. South Africa Market Revenue, By Product, 2016 – 2028
        • 6.6.6.2. South Africa Market Revenue, By Application, 2016 – 2028
      • 6.6.7. Rest of Middle-East Africa
        • 6.6.7.1. Rest of Middle-East Africa Market Revenue, By Product, 2016 – 2028
        • 6.6.7.2. Rest of Middle-East Africa Market Revenue, By Application, 2016 – 2028
  • Chapter No. 7: Human insulin Market – Industry Analysis
    • 7.1. Introduction
    • 7.2. Market Drivers
      • 7.2.1. Driving Factor 1 Analysis
      • 7.2.2. Driving Factor 2 Analysis
    • 7.3. Market Restraints
      • 7.3.1. Restraining Factor Analysis
    • 7.4. Market Opportunities
      • 7.4.1. Market Opportunity Analysis
    • 7.5. Porter’s Five Forces Analysis
    • 7.6. PEST Analysis
    • 7.7. Regulatory Landscape
    • 7.8. Technology Landscape
    • 7.9. Regional Market Trends
      • 7.9.1. North America
      • 7.9.2. Europe
      • 7.9.3. Asia Pacific
      • 7.9.4. Latin America
      • 7.9.5. The Middle-East and Africa
    • 7.10. Pricing Analysis
    • 7.11. Value Chain Analysis
    • 7.12. Downstream Buyers
    • 7.13. Distributors/Traders List
  • Chapter No. 8: Competitive Landscape
    • 8.1. Company Market Share Analysis – 2019
      • 8.1.1. Global Human insulin Market: Company Market Share, 2019
      • 8.1.2. Global Human insulin Market, Company Market Revenue, 2016 – 2019 (USD Billion)
      • 8.1.3. Global Human insulin Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 8.1.4. Global Human insulin Market: Radar Determinant Chart, 2019
    • 8.2. Strategic Developments
      • 8.2.1. Acquisitions & Mergers
      • 8.2.2. New Product Launch
      • 8.2.3. Regional Expansion
    • 8.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 9: Company Profiles
    • 9.1. GlaxoSmithCline
      • 9.1.1. Company Overview
      • 9.1.2. Key Executives
      • 9.1.3. Product Portfolio
      • 9.1.4. Financial Overview
      • 9.1.5. Operating Business Segments
      • 9.1.6. Business Performance
      • 9.1.7. Recent Developments
    • 9.2. Eli Lilly
    • 9.3. Sanofi-Aventis
    • 9.4. Biocon
    • 9.5. Novo Nordisk
    • 9.6. Julphar
    • 9.7. Ypsomed AG
    • 9.8. SemBioSys
    • 9.9. Wockhardt
  • Chapter No. 10: Marketing Strategy Analysis
    • 10.1. Marketing Channel
    • 10.2. Direct Marketing
    • 10.3. Indirect Marketing
    • 10.4. Marketing Channel Development Trends
    • 10.5. Economic/Pulitical Environmental Change
  • Chapter No. 11: Research Methodology
    • 11.1. Research Methodology
    • 11.2. Phase I - Secondary Research
    • 11.3. Phase II - Data Modeling
      • 11.3.1. Company Share Analysis Model
      • 11.3.2. Revenue Based Modeling
    • 11.4. Phase III - Primary Research
    • 11.5. Research Limitations
      • 11.5.1. Assumptions

Table Of Figures

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Product
FIG NO. 2. Market Attractiveness Analysis, By Application
FIG NO. 3. Market Attractiveness Analysis, By Region
FIG NO. 4. Global Human insulin Market Revenue, 2016 – 2028 (USD Billion)
FIG NO. 5. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 6. Market Revenue Share, By Product, 2020 & 2028 
FIG NO. 7. Global Human insulin Market for Drugs, Revenue (USD Billion) 2016 – 2028
FIG NO. 8. Comparative Revenue Analysis of Human insulin Market for Drugs, By Country, 2020 & 2028
FIG NO. 9. Global Human insulin Market for Drug Delivery Devices, Revenue (USD Billion) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of Human insulin Market for Drug Delivery Devices, By Country, 2020 & 2028
FIG NO. 15. Market Revenue Share, By Application, 2020 & 2028
FIG NO. 16. Global Human insulin Market for Insulin dependent diabetes mellitus (Type 1), Revenue (USD Billion) 2016 – 2028
FIG NO. 17. Comparative Revenue Analysis of Human insulin Market for Insulin dependent diabetes mellitus (Type 1), By Country, 2020 & 2028 
FIG NO. 18. Global Human insulin Market for Non-Insulin dependent diabetes mellitus (Type 2), Revenue (USD Billion) 2016 – 2028
FIG NO. 19. Comparative Revenue Analysis of Human insulin Market for Non-Insulin dependent diabetes mellitus (Type 2), By Country, 2020 & 2028
FIG NO. 20. Global Human insulin Market Revenue Share, By Region, 2020 & 2028
FIG NO. 21. North America Human insulin Market Revenue, 2016 - 2028 (USD Billion)
FIG NO. 22. Porter’s Five Forces Analysis for Global Human insulin Market
FIG NO. 23. PEST Analysis for Global Human insulin Market
FIG NO. 24. Pricing Analysis for Global Human insulin Market
FIG NO. 25. Value Chain Analysis for Global Human insulin Market
FIG NO. 26. Company Share Analysis, 2019
FIG NO. 27. Radar Determinant Chart, 2019
FIG NO. 28. Company Strategic Developments – Heat Map Analysis
FIG NO. 29. GlaxoSmithCline Business Segment Revenue Share, 2020 (%)
FIG NO. 30. GlaxoSmithCline Geographical Segment Revenue Share, 2020 (%)
FIG NO. 31. Market Channels
FIG NO. 32. Marketing Channel Development Trend
FIG NO. 33. Growth in World Gross Product, 2008-2018
FIG NO. 34. Research Methodology – Detailed View
FIG NO. 35. Research Methodology


Table Of Tables

List of Tables 

TABLE NO. 1. Global Human insulin Market: Snapshot
TABLE NO. 2. Quarterly Human insulin Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Human insulin Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion) 
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion) 
TABLE NO. 6. Global Human insulin Market for Drugs, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 7. Global Human insulin Market for Drug Delivery Devices, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 8. Global Human insulin Market for Insulin dependent diabetes mellitus (Type 1), by Region, 2016 – 2028 (USD Billion)
TABLE NO. 9 Global Human insulin Market for Non-Insulin dependent diabetes mellitus (Type 2), by Region, 2016 – 2028 (USD Billion)
TABLE NO. 10. Global Human insulin Market Revenue, By Region, 2016 – 2028 (USD Billion)
TABLE NO. 11. North America Human insulin Market Revenue, By Country, 2016 – 2028 (USD Billion)
TABLE NO. 12. North America Human insulin Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 13. North America Human insulin Market Revenue, By Application, 2016 – 2028 (USD Billion)
TABLE NO. 14. U.S. Human insulin Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 15. U.S. Human insulin Market Revenue, By Application, 2016 – 2028 (USD Billion)
TABLE NO. 16. Canada Human insulin Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 17. Canada Human insulin Market Revenue, By Application, 2016 – 2028 (USD Billion)
TABLE NO. 18. Mexico Human insulin Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 19. Mexico Human insulin Market Revenue, By Application, 2016 – 2028 (USD Billion)
TABLE NO. 20. Drivers for the Human insulin Market: Impact Analysis
TABLE NO. 21. Restraints for the Human insulin Market: Impact Analysis
TABLE NO. 22. Major Buyers of Human insulin  
TABLE NO. 23. Distributors/Traders List of Human insulin
TABLE NO. 24. Global Human insulin Market, Company Market Revenue, 2016 – 2019 (USD Billion)
TABLE NO. 25: Global Human insulin Market, Company Y-o-Y Growth, 2017 – 2019 (USD Billion)   


 

Methodology

FrequentlyAsked Questions

The global Human insulin Market was valued at USD 21.88 Billion in 2023.

The global Human insulin Market is expected to reach USD 48.51 Billion by 2032, growing at a CAGR of 8.3% between 2024 to 2032.

Some of the key factors driving the global Human insulin Market growth are the rising market demand for human insulin analogs, increasing risk of diabetes, favorable medical reimbursements, and technological enactments.

North America has been leading the worldwide human insulin market and is anticipated to continue on the dominant position in the years to come.

Some of the major players of global Human insulin market GlaxoSmithCline, Eli Lilly, Sanofi-Aventis, Biocon, Novo Nordisk, Julphar, Ypsomed AG, SemBioSys, and Wockhardt, among others.

Choose License Type

  • zion payment modes

List of Contents

Global Market InsightsHuman Insulin Market OverviewHuman Insulin Market Growth FactorsReport ScopeSegment Analysis Preview Regional Analysis Preview Key Market Players Competitive LandscapeThe global Market is segmented as follows:

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed